Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urogenital Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms 1 Liver Neoplasms 1 Genital Neoplasms, Female 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Advanced Primary Liver Cancer 1 Adrenocortical Carcinoma 1

Interventions

pembrolizumab 1 lenvatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Adrenocortical Carcinoma × lenvatinib × Clear all

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡